根据妊娠糖尿病的不同葡萄糖值的新生儿结局:基于登记的研究
Kaisa Kariniemi1,2, Marja Vääräsmäki1,2, Tuija Männistö3,4
1Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Kajaanintie 50, 90220, Oulu, Finland.
BMC pregnancy and childbirth
|April 12, 2024
概括
与正常葡萄糖水平相比,怀孕中的轻度高血糖症并没有增加新生儿不良后果. 这一发现表明,目前对于妊娠糖尿病 (GDM) 的诊断值是充足的.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿医学 新生儿医学
- 内分泌学 在内分泌学.
背景情况:
- 怀孕期间轻度高血糖症与出生体重增加有关,但其对其他新生儿结局的影响仍在争论中.
- 本研究研究了使用各种口服葡萄糖耐受性测试 (OGTT) 标准的轻度,未经治疗的高血糖症的新生儿结局.
研究的目的:
- 评估轻度未经治疗的高血糖和新生儿不良结果之间的关联.
- 为了将这些结果与正常血糖控制和治疗妊娠糖尿病 (GDM) 组进行比较.
- 评估不同OGTT值在确定临床相关GDM时的充分性.
主要方法:
- 这是一项基于登记的研究,对4,939名单身孕妇进行了在芬兰的75克2小时的OGTT.
- 根据芬兰,IADPSG和NICE标准定义轻度未治疗的高血糖症,将其与治疗的GDM和正常血糖控制区分开来.
- 使用多变量逻辑回归分析了一组新生儿不良结果 (低血糖,高血糖,出生创伤,周围死亡率).
主要成果:
- 与对照组相比,轻度未治疗的高血糖症没有增加新生儿不良后果的风险 (aOR 1.01-1.05).
- 与接受治疗的GDM组相比,未经治疗的轻度高血糖症中不良结果的风险明显较低 (aOR 0.32-0.38).
结论:
- 轻度未治疗的高血糖症与新生儿不良后果的风险增加无关.
- 目前芬兰OGTT对GDM的切线值 (禁食≥5.3 mmol/L,2小时≥8.6 mmol/L) 似乎足以识别临床相关病例.
- 这些门有效地识别GDM,但不排除新生儿面临不良结果的风险.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
924
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
924
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K


